Background Study definition

Background Study means the study required prior to passage of this By-law of the increases in services, and the capital costs associated therewith, projected as a result of development;
View Source
Background Study means the review of records conducted by the commissioner to determine whether a subject is disqualified from direct contact with persons served by a program, and where specifically provided in statutes, whether a subject is disqualified from having access to persons served by a program.
View Source
Background Study means the Development Charges Background Study prepared by Watson & Associates Economists Ltd., dated December 21, 2023, as amended by the Addendum to the
View Source

Examples of Background Study in a sentence

  • The location of all alternatives selected for detailed study shall be presented on a map or maps as part of the Archeological Background Study.

  • The Archeological Background Study shall identify any areas proposed for field investigation where impacts are deep, extending beyond three feet in depth.

  • Based on this review, the Archeological Background Study shall identify and plot on a map the areas that require field investigation to evaluate the project’s effects on archeological resources and cemeteries and shall identify the areas in which the proposed project would have no effect on archeological resources and cemeteries.

  • For projects in which an Archeological Background Study has already been completed by the Engineer and the project has materially changed --affecting the project limits, proposed new right of way (if any), easements (if any), any other project-specific location designated by the State, and/or the depth of impacts -- the Archeological Background Study shall incorporate the previous study by reference and focus on the project changes.

  • The Archeological Background Study shall conform to the current Review Standard for Archeological Background Studies, available from the State.

  • The Background Study shall be produced by a professional archeologist as defined in 13 TAC §26.4(2).

  • To conduct the Archeological Background Study, the professional archeologist shall undertake a review of existing data, including, but not limited to, the Texas Archeological Sites Atlas, geologic maps, soil maps, Potential Archeological Liability Map (PALM) of the project area (if applicable), aerial photographs, and historic maps.

  • Unless the Engineer has previously completed an Archeological Background Study for the project, the Archeological Background Study must define and consider all alternatives selected for detailed study, including all existing right of way, all proposed new right of way, easements (temporary and permanent), and any other project-specific location designated by the State.

  • The Background Study shall be produced by a professional archeologist as defined in 13 TAC §26.5(52)(B).

  • An Archeological Background Study shall be sufficient to satisfy the current Environmental Compliance Toolkit for Background Studies, available from the State.


More Definitions of Background Study

Background Study means the Development Charge Background Study prepared by Watson & Associates Economists Ltd., dated December 20, 2023 and adopted by Council;
View Source

Related to Background Study

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.